Clinical Trial Update: Imaging Studies of Kidney Cancer Using 18F-VM4-037 [Phase 2]

View source ↗

Summary

The NCI-sponsored Phase 2 imaging trial of the radiotracer 18F-VM4-037 for renal cell carcinoma and other kidney neoplasms has been terminated, with results pos…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Kidney Neoplasms
• Renal Cell Carcinoma

Drugs mentioned

• [18F]VM4-037 (VM4-037)

Snippet

Sponsor: National Cancer Institute (NCI) | Conditions: Carcinoma, Renal Cell, Kidney Neoplasms | Phase 2 | Status: TERMINATED | Results posted: 2014-09-19